Exogenous administration of endogenous compounds: an emerging drug-development strategy in critical care pharmacology.
Fink
M P
MP
D000241:Adenosine / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D003422:Critical Care; D015195:Drug Design; D006801:Humans; D007288:Inosine / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice
D007288:Inosine; D000241:Adenosine